Advertisement

How to select patients for atrial fibrillation ablation

  • Hakan Oral
    Correspondence
    Address reprint requests and correspondence: Dr. Hakan Oral, Division of Cardiovascular Medicine, University of Michigan, TC B1 140D, Electrophysiology, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-0311.
    Affiliations
    Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
    Search for articles by this author
  • Fred Morady
    Affiliations
    Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
    Search for articles by this author
Published:January 25, 2006DOI:https://doi.org/10.1016/j.hrthm.2006.01.016
      The goals of therapy for atrial fibrillation (AF) are elimination of symptoms and improvement in quality of life; prevention of complications such as thromboembolic events and tachycardia-mediated cardiomyopathy; and, at least in theory, improvement in survival.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hsu L.F.
        • Jais P.
        • Sanders P.
        • Garrigue S.
        • Hocini M.
        • Sacher F.
        • Takahashi Y.
        • Rotter M.
        • Pasquie J.L.
        • Scavee C.
        • Bordachar P.
        • Clementy J.
        • Haissaguerre M.
        Catheter ablation for atrial fibrillation in congestive heart failure.
        N Engl J Med. 2004; 351: 2373-2383
        • Lemola K.
        • Sneider M.
        • Desjardins B.
        • Case I.
        • Chugh A.
        • Hall B.
        • Cheung P.
        • Good E.
        • Han J.
        • Tamirisa K.
        • Bogun F.
        • Pelosi Jr, F.
        • Kazerooni E.
        • Morady F.
        • Oral H.
        Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins.
        Heart Rhythm. 2004; 1: 576-581
        • Oral H.
        • Pappone C.
        • Chugh A.
        • Good E.
        • Bogun F.
        • Pelosi Jr, F.
        • Bates E.
        • Lehmann M.
        • Vicedomini G.
        • Augello G.
        • Agricola E.
        • Sala S.
        • Santinelli V.
        • Morady F.
        Circumferential pulmonary vein ablation for chronic atrial fibrillation.
        N Engl J Med. 2006; 354: 934-941
        • Lemola K.
        • Desjardins B.
        • Sneider M.
        • Case I.
        • Chugh A.
        • Good E.
        • Han J.
        • Tamirisa K.
        • Tsemo A.
        • Reich S.
        • Tschopp D.
        • Igic P.
        • Elmouchi D.
        • Bogun F.
        • Pelosi Jr, F.
        • Kazerooni E.
        • Morady F.
        • Oral H.
        Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function.
        Heart Rhythm. 2005; 2: 923-928
        • Wyse D.G.
        • Waldo A.L.
        • DiMarco J.P.
        • Domanski M.J.
        • Rosenberg Y.
        • Schron E.B.
        • Kellen J.C.
        • Greene H.L.
        • Mickel M.C.
        • Dalquist J.E.
        • Corley S.D.
        A comparison of rate control and rhythm control in patients with atrial fibrillation.
        N Engl J Med. 2002; 347: 1825-1833
        • Corley S.D.
        • Epstein A.E.
        • DiMarco J.P.
        • Domanski M.J.
        • Geller N.
        • Greene H.L.
        • Josephson R.A.
        • Kellen J.C.
        • Klein R.C.
        • Krahn A.D.
        • Mickel M.
        • Mitchell L.B.
        • Nelson J.D.
        • Rosenberg Y.
        • Schron E.
        • Shemanski L.
        • Waldo A.L.
        • Wyse D.G.
        Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
        Circulation. 2004; 109: 1509-1513
        • Pappone C.
        • Rosanio S.
        • Augello G.
        • Gallus G.
        • Vicedomini G.
        • Mazzone P.
        • Gulletta S.
        • Gugliotta F.
        • Pappone A.
        • Santinelli V.
        • Tortoriello V.
        • Sala S.
        • Zangrillo A.
        • Crescenzi G.
        • Benussi S.
        • Alfieri O.
        Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation.
        J Am Coll Cardiol. 2003; 42: 185-197
        • Kottkamp H.
        • Tanner H.
        • Kobza R.
        • Schirdewahn P.
        • Dorszewski A.
        • Gerds-Li J.H.
        • Carbucicchio C.
        • Piorkowski C.
        • Hindricks G.
        Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure?.
        J Am Coll Cardiol. 2004; 44: 869-877
        • Cappato R.
        • Calkins H.
        • Chen S.A.
        • Davies W.
        • Iesaka Y.
        • Kalman J.
        • Kim Y.H.
        • Klein G.
        • Packer D.
        • Skanes A.
        Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.
        Circulation. 2005; 111: 1100-1105
        • Chan P.
        • Vijan S.
        • Morady F.
        • Oral H.
        Cost-effectiveness of left atrial catheter ablation, antiarrhythmic therapy, and rate control for paroxysmal and chronic atrial fibrillation.
        J Am Coll Cardiol. 2005; 45: 125A
        • Wazni O.M.
        • Marrouche N.F.
        • Martin D.O.
        • Verma A.
        • Bhargava M.
        • Saliba W.
        • Bash D.
        • Schweikert R.
        • Brachmann J.
        • Gunther J.
        • Gutleben K.
        • Pisano E.
        • Potenza D.
        • Fanelli R.
        • Raviele A.
        • Themistoclakis S.
        • Rossillo A.
        • Bonso A.
        • Natale A.
        Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation.
        JAMA. 2005; 293: 2634-2640
        • Lang C.C.
        • Santinelli V.
        • Augello G.
        • Ferro A.
        • Gugliotta F.
        • Gulletta S.
        • Vicedomini G.
        • Mesas C.
        • Paglino G.
        • Sala S.
        • Sora N.
        • Mazzone P.
        • Manguso F.
        • Pappone C.
        Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria.
        J Am Coll Cardiol. 2005; 45: 868-872
        • Oral H.
        • Hall B.
        • Chugh A.
        • Cheung P.
        • Lemola K.
        • Good E.
        • Tamirisa K.
        • Han J.
        • Bogun F.
        • Pelosi Jr, F.
        • Morady F.
        Age and catheter ablation for atrial fibrillation (abstr).
        Circulation. 2004; 110: 348